[1]
2023. Investigation of dual anti-HIV/HSV activity of oxoquinoline-acylhydrazone derivatives by molecular docking. Brazilian Journal of Pharmaceutical Sciences. 59, (Nov. 2023), e23263. DOI:https://doi.org/10.1590/s2175-97902023e23263.